Philip C Caron MD
Assistant Professor, Medicine, Weill Cornell Medical College
Join to view full profile
500 Westchester AvenueWest Harrison, NY 10604
Phone+1 914-367-7369
Fax+1 646-227-7283
Dr. Caron is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1986 - 1989
New York Medical CollegeClass of 1986
Columbia UniversityPhD, Pathobiology, 1978 - 1984
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 1987 - 2028
NJ State Medical License 2019 - 2027
CT State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Westchester Magazine: Top Doctors Castle Connolly
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
Publications & Presentations
PubMed
- Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.Sean E Healton, Manik Uppal, Pallavi K Galera, Efrat Luttwak, Alfredo Rivas-Delgado
Blood Advances. 2026-07-10 - Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.Jacob D Soumerai, Meghan C Thompson, Ahmet Dogan, Venkatraman E Seshan, Kelsey Flaherty
Blood Advances. 2026-06-30 - 1 citationsTwo decades of single-institution data reveal rare longterm survivors of relapsed/refractory Burkitt lymphoma.Rabeya Molla, Kurt Bantilan, Ellin Berman, Philip Caron, Lorenzo Falchi
Haematologica. 2026-01-01
Abstracts/Posters
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...Philip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaPhilip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaPhilip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Grant Support
- Targeted Sequential Therapy For CMLNational Cancer Institute1997–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
